363 related articles for article (PubMed ID: 11413739)
21. Histamine skin test reactivity following single and multiple doses of azelastine nasal spray in patients with seasonal allergic rhinitis.
Pearlman DS; Grossman J; Meltzer EO
Ann Allergy Asthma Immunol; 2003 Sep; 91(3):258-62. PubMed ID: 14533657
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis.
Banov CH; Lieberman P;
Ann Allergy Asthma Immunol; 2001 Jan; 86(1):28-35. PubMed ID: 11206234
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine.
Berger WE; White MV;
Ann Allergy Asthma Immunol; 2003 Aug; 91(2):205-11. PubMed ID: 12952117
[TBL] [Abstract][Full Text] [Related]
24. Sequential therapy with azelastine in seasonal allergic rhinitis. Deutsche Rhinitis Studiengruppe (German Rhinitis Study Group).
Kremer B; Klimek L; Gülicher D; Degen M; Mösges R
Arzneimittelforschung; 1999 Nov; 49(11):912-9. PubMed ID: 10604044
[TBL] [Abstract][Full Text] [Related]
25. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy.
Horak F; Zieglmayer UP; Zieglmayer R; Kavina A; Marschall K; Munzel U; Petzold U
Curr Med Res Opin; 2006 Jan; 22(1):151-7. PubMed ID: 16393441
[TBL] [Abstract][Full Text] [Related]
26. [Clinical assessment of azelastine nasal spray in seasonal allergic rhinitis].
Arcimowicz M; Samoliński B; Zawisza E
Pol Merkur Lekarski; 1998 Dec; 5(30):363-7. PubMed ID: 10101526
[TBL] [Abstract][Full Text] [Related]
27. A randomized double-blind placebo controlled study of azelastine nasal spray in children with perennial rhinitis.
Herman D; Garay R; Le Gal M
Int J Pediatr Otorhinolaryngol; 1997 Feb; 39(1):1-8. PubMed ID: 9051434
[TBL] [Abstract][Full Text] [Related]
28. Efficacy, cost-effectiveness, and tolerability of mometasone furoate, levocabastine, and disodium cromoglycate nasal sprays in the treatment of seasonal allergic rhinitis.
Lange B; Lukat KF; Rettig K; Holtappels G; Bachert C
Ann Allergy Asthma Immunol; 2005 Sep; 95(3):272-82. PubMed ID: 16200819
[TBL] [Abstract][Full Text] [Related]
29. Onset of action, effectiveness and tolerance of levocabastine and nedocromil in topical therapy of seasonal allergic rhinoconjunctivitis. The Deutsche Rhinitis-Studiengruppe.
Kremer B; Tündermann A; Goldschmidt O
Arzneimittelforschung; 1998 Sep; 48(9):924-30. PubMed ID: 9793620
[TBL] [Abstract][Full Text] [Related]
30. The effect of intranasal azelastine and beclomethasone on the symptoms and signs of nasal allergy in patients with perennial allergic rhinitis.
Davies RJ; Lund VJ; Harten-Ash VJ
Rhinology; 1993 Dec; 31(4):159-64. PubMed ID: 7908144
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of azelastine 0.15% nasal spray administered once daily in subjects with seasonal allergic rhinitis.
van Bavel J; Howland WC; Amar NJ; Wheeler W; Sacks H
Allergy Asthma Proc; 2009; 30(5):512-8. PubMed ID: 19747429
[TBL] [Abstract][Full Text] [Related]
32. The efficacy and tolerability of two novel H(1)/H(3) receptor antagonists in seasonal allergic rhinitis.
Daley-Yates P; Ambery C; Sweeney L; Watson J; Oliver A; McQuade B
Int Arch Allergy Immunol; 2012; 158(1):84-98. PubMed ID: 22212854
[TBL] [Abstract][Full Text] [Related]
33. Investigation on the efficacy and tolerance of azelastine (HCL) nasal spray versus ebastine tablets in patients with seasonal allergic rhinitis.
Conde Hernández J; Palma Aguilar JL; Delgado Romero J
Allergol Immunopathol (Madr); 1995; 23(2):51-7. PubMed ID: 8526167
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of azelastine nasal solution in seasonal allergic rhinitis.
Storms WW; Pearlman DS; Chervinsky P; Grossman J; Halverson PC; Freitag JJ; Widlitz MD
Ear Nose Throat J; 1994 Jun; 73(6):382-6, 390-4. PubMed ID: 8076537
[TBL] [Abstract][Full Text] [Related]
35. Double-blind comparison of levocabastine nasal spray with sodium cromoglycate nasal spray in the treatment of seasonal allergic rhinitis.
Palma-Carlos AG; Chieira C; Conde TA; Cordeiro JA
Ann Allergy; 1991 Oct; 67(4):394-8. PubMed ID: 1683189
[TBL] [Abstract][Full Text] [Related]
36. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device.
Hampel FC; Ratner PH; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
Ann Allergy Asthma Immunol; 2010 Aug; 105(2):168-73. PubMed ID: 20674829
[TBL] [Abstract][Full Text] [Related]
37. Double-blind trials of azelastine nasal spray monotherapy versus combination therapy with loratadine tablets and beclomethasone nasal spray in patients with seasonal allergic rhinitis. Rhinitis Study Groups.
Berger WE; Fineman SM; Lieberman P; Miles RM
Ann Allergy Asthma Immunol; 1999 Jun; 82(6):535-41. PubMed ID: 10400480
[TBL] [Abstract][Full Text] [Related]
38. Treatment of severe seasonal rhinoconjunctivitis by a combination of azelastine nasal spray and eye drops: a double-blind, double-placebo study.
Duarte C; Baëhre M; Gharakhanian S; Leynadier F;
J Investig Allergol Clin Immunol; 2001; 11(1):34-40. PubMed ID: 11436969
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of azelastine 0.15% nasal spray administered once daily in patients with allergy to Texas mountain cedar pollen.
Howland WC; Amar NJ; Wheeler W; Sacks H
Int Forum Allergy Rhinol; 2011; 1(4):275-9. PubMed ID: 22287431
[TBL] [Abstract][Full Text] [Related]
40. Intranasal levocabastine provides fast and effective protection from nasal allergen challenge.
Bachert C; Wagenmann M; Vossen-Holzenkamp S
Rhinology; 1996 Sep; 34(3):140-3. PubMed ID: 8938880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
